lg 100268 has been researched along with Acute Myelogenous Leukemia in 1 studies
LG 100268: a retinoid X receptor (RXR) selective compound; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sanchez, PV | 1 |
| Glantz, ST | 1 |
| Scotland, S | 1 |
| Kasner, MT | 1 |
| Carroll, M | 1 |
1 other study available for lg 100268 and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors.
Topics: Bexarotene; CCAAT-Enhancer-Binding Protein-alpha; CCAAT-Enhancer-Binding Proteins; Cell Differentiat | 2014 |